Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Rosalind Advisors, Inc. (CIK 1622627) reported $269.2M across 29 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: DCTH ($41.6M, 15.44%), FENC ($34.3M, 12.73%), XERS ($23.0M, 8.56%), SVRA ($19.6M, 7.27%), VSTM ($15.2M, 5.66%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | $41.6M | 15.44% | 3.3M | Hold |
| 2 | FENC | FENNEC PHARMACEUTICALS INC | $34.3M | 12.73% | 3.2M | Added |
| 3 | XERS | XERIS BIOPHARMA HOLDINGS INC | $23.0M | 8.56% | 2.9M | Trimmed |
| 4 | SVRA | SAVARA INC | $19.6M | 7.27% | 3.2M | Trimmed |
| 5 | VSTM | VERASTEM INC | $15.2M | 5.66% | 4.0M | Added |
| 6 | XFOR | X4 PHARMACEUTICALS INC | $15.0M | 5.58% | 3.2M | Hold |
| 7 | EYPT | EYEPOINT PHARMACEUTICALS INC | $14.1M | 5.25% | 988,230 | Trimmed |
| 8 | HELP | CYBIN INC | $12.9M | 4.80% | 2.0M | Added |
| 9 | VOR | VOR BIOPHARMA INC | $11.9M | 4.44% | 648,600 | Trimmed |
| 10 | PCVX | VAXCYTE INC | $11.6M | 4.32% | 200,000 | Trimmed |
| 11 | MDWD | MEDIWOUND LTD | $11.0M | 4.09% | 749,054 | Hold |
| 12 | CLDX | CELLDEX THERAPEUTICS INC | $7.4M | 2.76% | 200,000 | Trimmed |
| 13 | BCRX | BIOCRYST PHARMACEUTICALS INC | $7.2M | 2.68% | 721,504 | Trimmed |
| 14 | PROF | PROFOUND MEDICAL CORP | $5.5M | 2.05% | 828,118 | Hold |
| 15 | TLPH | TALPHERA INC | $5.3M | 1.98% | 5.2M | Added |
| 16 | AVIR | ATEA PHARMACEUTICALS INC | $5.0M | 1.85% | 1.1M | Trimmed |
| 17 | MYO | MYOMO INC | $3.8M | 1.41% | 3.6M | Trimmed |
| 18 | OVID | OVID THERAPEUTICS INC | $3.0M | 1.11% | 1.1M | Hold |
| 19 | NRXS | NEURAXIS INC | $3.0M | 1.10% | 508,055 | Added |
| 20 | ABVX | ABIVAX SA | $2.8M | 1.03% | 20,869 | New |
| 21 | NSPR | INSPIREMD INC | $2.7M | 1.02% | 3.9M | Hold |
| 22 | RGNT | REGENTIS BIOMATERIALS LTD | $2.5M | 0.92% | 701,685 | Added |
| 23 | SLS | SELLAS LIFE SCIENCES GROUP INC | $2.3M | 0.86% | 568,700 | New |
| 24 | PYPD | POLYPID LTD | $2.0M | 0.73% | 389,455 | Trimmed |
| 25 | BFRI | BIOFRONTERA INC | $1.2M | 0.45% | 1.3M | Added |
Source: SEC Form 13F filings · as of 2026-06-30